Effectiveness of Cabergoline Treatment in Patients with Acromegaly Uncontrolled with SSAs: Experience of a Single Tertiary Center

---

Atıf İçin Kopyala

Sahin S., Fidan M. C., Korkmaz O. P., DURCAN E., ÖZKAYA H. M., KADIOĞLU P.

EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, cilt.129, sa.9, ss.644-650, 2021 (SCI-Expanded)

• Yayın Türü: Makale / Tam Makale
• Cilt numarası: 129 Sayı: 9
• Basım Tarihi: 2021
• Doi Numarası: 10.1055/a-1274-1276
• Dergi Adı: EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
• Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, BIOSIS, CAB Abstracts, Chemical Abstracts Core, EMBASE, MEDLINE, Veterinary Science Database
• Sayfa Sayıları: ss.644-650
• Anahtar Kelimeler: Acromegaly, cabergoline, combined therapy, somatostatin analogue
• İstanbul Üniversitesi Adresli: Evet

Özet

Purpose To evaluate the effectiveness of cabergoline and the parameters affecting cabergoline response as add-on treatment to somatostatin analaogues (SSA) in patients with acromegaly uncontrolled with SSAs.